Kairos Pharma (KAPA) Stock: Buy, Sell, or Hold?
$0.48
-0.03 (-5.75%)
▼
5d:
+5.72%
30d:
-35.32%
90d:
+40.94%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (77%)
Quality Score
58/100
Position
SLIGHTLY LOW
30-Day Fair Range
$0.41 – $0.89
Position: SLIGHTLY LOW
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$49.00
+10096.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.42 / $0.55
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: KAPA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When KAPA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: KAPA is currently trading at $0.48, which is considered slightly low relative to its 30-day fair value range of $0.41 to $0.89.
Technical Outlook: Technically, KAPA is in a uptrend. Immediate support is located at $0.42, while resistance sits at $0.55. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $49.00 (+10096.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KAPA is in a uptrend. Immediate support is located at $0.42, while resistance sits at $0.55. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $49.00 (+10096.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.41 -
$0.89
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$0.41 -
$0.89
Current vs Trading Range
SLIGHTLY LOW
Support Level
$0.42
Resistance Level
$0.55
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.7%)
- BULLISH: Trading 10096.1% below Wall St target ($49.00)
- NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-0.10
Wall Street Target
$49.00
(+10096.1%)
Share KAPA Analysis
Share this live KAPA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (KAPA)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Scage Future Entering Strategic Cooperation Agreement with China Huaye Group. Bullish sentiment builds around the potential growth opportunities for SCAG due to this collaboration.
Key Retail Themes:
strategic cooperation
growth potential
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:36 AM ET
Data refreshes hourly during market hours. Next update: 5:36 AM
Data refreshes hourly during market hours. Next update: 5:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KAPA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive KAPA Research Pages
